Sunrise Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11K Sell
455
-79
-15% -$2.07K 0.01% 227
2026
Q1
$15K Buy
534
+79
+17% +$2.1K 0.01% 200
2025
Q4
$11.3K Buy
+455
New +$11.5K 0.01% 203

Other funds holding PFE

Sunrise Financial Services's PFE Position: Q2 2026 in Review

Sunrise Financial Services reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $2.07K and leaving 455 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #227.

Sunrise Financial Services first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $15K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sunrise Financial Services held 455 shares of Pfizer worth $11K as of Q2 2026.
  • Sunrise Financial Services sold 79 Pfizer shares in Q2 2026, an estimated $2.07K.
  • Pfizer made up 0.01% of Sunrise Financial Services's portfolio in Q2 2026, its #227 holding.
  • Sunrise Financial Services first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Sunrise Financial Services's Pfizer position peaked at $15K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sunrise Financial Services's 13F filing for Q2 2026, filed 12 Aug 2026.